Public Health Agency of Canada

253 articles with Public Health Agency of Canada

• Government of Canada Invests in Dementia Data and Community-based Projects

  1/21/2021

  The Honourable Patty Hajdu, Minister of Health, announced six new initiatives that will help implement Canada's national dementia strategy.

• Statement from the Chief Public Health Officer of Canada on January 21, 2021

  1/21/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on January 20, 2021

  1/20/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)

  1/20/2021

  Aptorum Group Limited announced that the company, through its wholly owned subsidiary, Aptorum International Limited, has received clearance from the Public Health Agency of Canada regarding the Clinical Trial Application to commence a Phase 1 study of ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus including MRSA.

• Statement from the Chief Public Health Officer of Canada on January 18, 2021

  1/18/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on January 17, 2021

  1/17/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians, public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on January 16, 2021

  1/16/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on January 11, 2021

  1/11/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Government of Canada Announces Funding for New COVID-19 Safe Voluntary Isolation Centre in Waterloo, Ontario

  1/11/2021

  The Government of Canada remains committed to protecting the health and safety of Canadians and reducing the spread of COVID-19 in Canada.

• CPHO Issue Statement Series on COVID-19: mRNA Vaccines

  1/10/2021

  The end of 2020 marked a turning point for Canada in our fight against COVID-19. We witnessed Canadian approval of the first two vaccines for COVID-19 - the Pfizer-BioNTech vaccine and the Moderna vaccine, and rollout of initial doses of these vaccines across the country.

• Statement from the Chief Public Health Officer of Canada on January 9, 2021

  1/9/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on January 7, 2021

  1/7/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• COVID-19 testing centre for arriving international travellers launches at Pearson Airport

  1/7/2021

  The Government of Canada welcomes the Government of Ontario's announcement to offer COVID-19 testing on-site at Toronto Pearson International Airport for arriving international travellers who wish to take a test prior to leaving the airport.

• Statement from the Chief Public Health Officer of Canada on January 6, 2021

  1/6/2021

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on December 31, 2020

  12/31/2020

  As we ring in the new year and bid farewell to 2020, we continue to track a range of epidemiological indicators to monitor COVID-19 activity and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Contravening mandatory quarantine requirements can result in severe penalties

  12/29/2020

  The Government of Canada continues to advise against non-essential travel and reminds all travellers returning to Canada that contravening the mandatory quarantine can lead to severe penalties.

• Statement on the variants of COVID-19 virus found in Ontario

  12/26/2020

  The Government of Canada has a monitoring program in place with the provinces and territories to identify new COVID-19 variants in Canada, such as the ones identified in the United Kingdom and South Africa.

• Statement from the Chief Public Health Officer of Canada on December 23, 2020

  12/23/2020

  As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

• Statement from the Chief Public Health Officer of Canada on December 21, 2020

  12/21/2020

  The Government of Canada is closely monitoring the genetic variant of the virus that causes COVID-19 identified in the United Kingdom and is working with international and other partners including the World Health Organization to better understand this variant and its impacts.

• Aptorum Group Announces Submission of Clinical Trial Application for ALS-4, an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)

  12/21/2020

  Aptorum Group Limited has submitted a Clinical Trial Application with the Public Health Agency of Canada to conduct a Phase 1 clinical trial of ALS-4, an orally administered small molecule drug for the treatment of infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus.